Vivos Therapeutics Expands Management Team to Support Growth and Expansion

Vivos Therapeutics, a medical technology company, has appointed Michael Bruhn as Executive Vice President of Business Operations Integration and Dr. Terry Jones as Senior Vice President of Human Resources. The hires support the company's expansion and growth, particularly in the Eastern United States, and focus on scaling revenue through acquisitions and collaborations. Both Bruhn and Jones have extensive experience in healthcare and will report directly to Vivos Chairman and CEO, R. Kirk Huntsman.

Vivos Therapeutics, Inc. (NASDAQ: VVOS) has recently announced significant additions to its management team, aiming to support its expansion and growth, particularly in the Eastern United States. The company appointed Michael (Mike) E. Bruhn as Executive Vice President of Business Operations Integration and Dr. Terry Jones as Senior Vice President of Human Resources [1].

Michael Bruhn, who will report directly to Vivos Chairman and CEO, R. Kirk Huntsman, brings extensive experience in healthcare and business operations. Before joining Vivos, Bruhn served as Executive Vice President and Chief Operating Officer at the United States Institute of Peace (USIP), where he oversaw a staff of approximately 300 people and a 2023 annual operating budget of around $55 million. He also held senior leadership roles in federal healthcare consulting and the U.S. Air Force Medical Service [1].

Dr. Terry Jones, who will also report to Huntsman, brings over two decades of distinguished leadership in federal agencies, international nonprofits, and the private sector. He most recently served as Vice President of Human Resources at USIP, where he played a pivotal role in strengthening organizational culture and enhancing talent management frameworks. Jones holds a Doctorate in Management, an MBA in Human Resources Management, and a Bachelor of Science in Business [1].

The appointments of Bruhn and Jones reflect Vivos' commitment to scaling its promising new sleep testing center and direct patient treatment operations. Vivos recently acquired The Sleep Center of Nevada and is actively exploring similar acquisitions or collaborations to drive revenue growth [1].

Bruhn will focus on expanding Vivos' operations under its new business model, with a particular emphasis on the Eastern United States. He will manage the integration of existing and new acquisitions and collaborations into Vivos' business, aiming to ensure seamless integration and scalable growth. Dr. Jones will oversee human resources, fostering a dynamic and high-performing team that supports Vivos' next phase of growth [1].

Vivos Therapeutics is a medical technology company focused on developing and commercializing innovative diagnostic and treatment methods for breathing and sleep issues such as obstructive sleep apnea (OSA) and snoring. The company's Complete Airway Repositioning and/or Expansion (CARE) devices are the only oral appliances cleared by the U.S. Food and Drug Administration (FDA) for adult patients diagnosed with all severity levels of OSA and moderate-to-severe OSA in children ages 6 to 17 [1].

References:
[1] https://www.streetinsider.com/Globe+Newswire/Vivos+Therapeutics+Adds+to+Management+Team%C2%A0to+Support+Expansion+and+Growth/25118425.html